title: Reactivation of hepatitis B virus 40 months after discontinuation of rituximab maintenance treatment and 5 months after cessation of entecavir administration.
authors.affiliation: Nanjing University of TCM, 210000 Nanjing, China; Department of Hematology, The affiliated Hospital of Nanjing University of TCM, Hanzhong Road 155, 210029 Nanjing, China.
authors.forename: Xing-Bin
authors.initials: XB
authors.lastname: Dai
authors.affiliation: Department of Hematology, The affiliated Hospital of Nanjing University of TCM, Hanzhong Road 155, 210029 Nanjing, China. Electronic address: xuemeisun2014@yeah.net.
authors.forename: Xue-Mei
authors.initials: XM
authors.lastname: Sun
authors.affiliation: Department of Hematology, The affiliated Hospital of Nanjing University of TCM, Hanzhong Road 155, 210029 Nanjing, China.
authors.forename: Xue-Jun
authors.initials: XJ
authors.lastname: Zhu
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000998:Antiviral Agents / Q000008:administration & dosage*; D017809:Fatal Outcome; D005260:Female; D006147:Guanine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006509:Hepatitis B / Q000209:etiology*; D006515:Hepatitis B virus / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D000069283:Rituximab / Q000008:administration & dosage*; D013997:Time Factors; D028761:Withholding Treatment
chemical_list: D000970:Antineoplastic Agents; D000998:Antiviral Agents; D000069283:Rituximab; C413685:entecavir; D006147:Guanine